Short hairpin RNA targeting of fibroblast activation protein inhibits tumor growth and improves the tumor microenvironment in a mouse model

BMB Reports

Volumn 46, Issue 5, 2013, Pages 252-257

  Cai, Fan ^a   Li, Zhiyong ^b   Wang, Chunting ^b   Xian, Shuang ^a   Xu, Guangchao ^b   Peng, Feng ^a   Wei, Yuquan ^b   Lu , You ^a  

^a SICHUAN UNIVERSITY   (China)

^b SICHUAN UNIVERSITY   (China)

Author keywords

Angiogenesis; Breast cancer; Fibroblast activation protein; RNA interference; Tumor microenvironment

Indexed keywords

GELATINASE; MEMBRANE PROTEIN; SEPRASE; SERINE PROTEINASE; SMALL INTERFERING RNA;

ANIMAL; APOPTOSIS; ARTICLE; BREAST TUMOR; DISEASE MODEL; DRUG ANTAGONISM; DRUG DELIVERY SYSTEM; DRUG EFFECT; FEMALE; GENE SILENCING; GENETICS; HUMAN; IMMUNOHISTOCHEMISTRY; MOUSE; TUMOR CELL LINE; TUMOR MICROENVIRONMENT;

ANIMALS; APOPTOSIS; BREAST NEOPLASMS; CELL LINE, TUMOR; DISEASE MODELS, ANIMAL; DRUG DELIVERY SYSTEMS; FEMALE; GELATINASES; GENE KNOCKDOWN TECHNIQUES; HUMANS; IMMUNOHISTOCHEMISTRY; MEMBRANE PROTEINS; MICE; RNA, SMALL INTERFERING; SERINE ENDOPEPTIDASES; TUMOR MICROENVIRONMENT;

EID: 84880626610     PISSN: 19766696     EISSN: 1976670X     Source Type: Journal    
DOI: 10.5483/BMBRep.2013.46.5.172     Document Type: Article

References (30)

1. Jemal, A., Siegel, R., Xu, J. and Ward, E. (2010) Cancer statistics, 2010. CA Cancer J. Clin. 60, 277-300.
2. Verma, S., Provencher, L. and Dent, R. (2011) Emerging trends in the treatment of triple-negative breast cancer in Canada: a survey. Curr. Oncol. 18, 180-190.
3. Rettig, W. J., Garin-Chesa, P., Beresford, H. R., Oettgen, H. F., Melamed, M. R. and Old, L. J. (1988) Cell-surface glycoproteins of human sarcomas: differential expression in normal and malignant tissues and cultured cells. Proc. Natl. Acad. Sci. U.S.A. 85, 3110-3114.
4. Kunz-Schughart, L. A. and Knuechel, R. (2002) Tumor-associated fibroblasts (part I): Active stromal participants in tumor development and progression? Histol. Histopathol. 17, 599-621.
5. Edosada, C. Y., Quan, C., Wiesmann, C., Tran, T., Sutherlin, D., Reynolds, M., Elliott, J. M., Raab, H., Fairbrother, W. and Wolf, B. B. (2006) Selective inhibition of fibroblast activation protein protease based on dipeptide substrate specificity. J. Biol. Chem. 281, 7437-7444.
6. Christiansen, V. J., Jackson, K. W., Lee, K. N. and McKee, P. A. (2007) Effect of fibroblast activation protein and alpha2-antiplasmin cleaving enzyme on collagen types I, III and IV. Arch. Biochem. Biophys. 457, 177-186.
7. Huang, Y., Wang, S. and Kelly, T. (2004) Seprase promotes rapid tumor growth and increased microvessel density in a mouse model of human breast cancer. Cancer Res. 64, 2712-2716.
8. Cheng, J. D., Dunbrack, R. L. Jr., Valianou, M., Rogatko, A., Alpaugh, R. K. and Weiner, L. M. (2002) Promotion of tumor growth by murine fibroblast activation protein, a serine protease, in an animal model. Cancer Res. 62, 4767-4772.
9. Pietras, K. and Ostman, A. (2010) Hallmarks of cancer: interactions with the tumor stroma. Exp. Cell Res. 316, 1324-1331.
10. Sliva, K. and Schnierle, B. S. (2010) Selective gene silencing by viral delivery of short hairpin RNA. Virol. J. 7, 248.
11. Hannon, G. J. and Rossi, J. J. (2004) Unlocking the potential of the human genome with RNA interference. Nature 431, 371-378.
12. Santel, A., Aleku, M., Keil, O., Endruschat, J., Esche, V., Durieux, B., Loffler, K., Fechtner, M., Rohl, T., Fisch, G., Dames, S., Arnold, W., Giese, K., Klippel, A. and Kaufmann, J. (2006) RNA interference in the mouse vascular endothelium by systemic administration of siRNA-lipoplexes for cancer therapy. Gene Ther. 13, 1360-1370.
13. Pirollo, K. F., Rait, A., Zhou, Q., Hwang, S. H., Dagata, J. A., Zon, G., Hogrefe, R. I., Palchik, G. and Chang, E. H. (2007) Materializing the potential of small interfering RNA via a tumor-targeting nanodelivery system. Cancer Res. 67, 2938-2943.
14. Wan, Y., Huang, A., Yang, Y., Xie, G., Chen, X., Hu, J., Yang, L., Li, J., Chen, L., Jiang, Y., Zhao, X., Wei, Y. and Deng, H. (2010) A vector-based short hairpin RNA targeting Aurora A inhibits breast cancer growth. Int. J. Oncol. 36, 1121-1128.
15. Mbeunkui, F. and Johann, D. J. Jr. (2009) Cancer and the tumor microenvironment: a review of an essential relationship. Cancer Chemother. Pharmacol. 63, 571-582.
16. Dvorak, H. F. (1986) Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing. N. Engl. J. Med. 315, 1650-1659.
17. Loeffler, M., Kruger, J. A., Niethammer, A. G. and Reisfeld, R. A. (2006) Targeting tumor-associated fibroblasts improves cancer chemotherapy by increasing intratumoral drug uptake. J. Clin. Invest. 116, 1955-1962.
18. Hofheinz, R. D., al-Batran, S. E., Hartmann, F., Hartung, G., Jager, D., Renner, C., Tanswell, P., Kunz, U., Amelsberg, A., Kuthan, H. and Stehle, G. (2003) Stromal antigen targeting by a humanised monoclonal antibody: an early phase II trial of sibrotuzumab in patients with metastatic colorectal cancer. Onkologie 26, 44-48.
19. Adams, S., Miller, G. T., Jesson, M. I., Watanabe, T., Jones, B. and Wallner, B. P. (2004) PT-100, a small molecule dipeptidyl peptidase inhibitor, has potent antitumor effects and augments antibody-mediated cytotoxicity via a novel immune mechanism. Cancer Res. 64, 5471-5480.
20. Santos, A. M., Jung, J., Aziz, N., Kissil, J. L. and Pure, E. (2009) Targeting fibroblast activation protein inhibits tumor stromagenesis and growth in mice. J. Clin. Invest. 119, 3613-3625.
21. Huang, Y., Simms, A. E., Mazur, A., Wang, S., Leon, N. R., Jones, B., Aziz, N. and Kelly, T. (2011) Fibroblast activation protein-alpha promotes tumor growth and invasion of breast cancer cells through non-enzymatic functions. Clin. Exp. Metastasis 28, 567-579.
22. Barcellos-Hoff, M. H. (2001) It takes a tissue to make a tumor: epigenetics, cancer and the microenvironment. J. Mammary Gland Biol. Neoplasia 6, 213-221.
23. Roskelley, C. D. and Bissell, M. J. (2002) The dominance of the microenvironment in breast and ovarian cancer. Semin. Cancer Biol. 12, 97-104.
24. Folkman, J. (1990) What is the evidence that tumors are angiogenesis dependent? J. Natl. Cancer Inst. 82, 4-6.
25. Provenzano, P. P., Eliceiri, K. W., Campbell, J. M., Inman, D. R., White, J. G. and Keely, P. J. (2006) Collagen reorganization at the tumor-stromal interface facilitates local invasion. BMC Med. 4, 38.
26. Netti, P. A., Berk, D. A., Swartz, M. A., Grodzinsky, A. J. and Jain, R. K. (2000) Role of extracellular matrix assembly in interstitial transport in solid tumors. Cancer Res. 60, 2497-2503.
27. Indran, I. R., Tufo, G., Pervaiz, S. and Brenner, C. (2011) Recent advances in apoptosis, mitochondria and drug resistance in cancer cells. Biochim. Biophys. Acta. 1807, 735-745.
28. Grimm, D., Wang, L., Lee, J. S., Schurmann, N., Gu, S., Borner, K., Storm, T. A. and Kay, M. A. (2010) Argonaute proteins are key determinants of RNAi efficacy, toxicity and persistence in the adult mouse liver. J. Clin. Invest. 120, 3106-3119.
29. Wen, Y., Wang, C. T., Ma, T. T., Li, Z. Y., Zhou, L. N., Mu, B., Leng, F., Shi, H. S., Li, Y. O. and Wei, Y. Q. (2010) Immunotherapy targeting fibroblast activation protein inhibits tumor growth and increases survival in a murine colon cancer model. Cancer Sci. 101, 2325-2332.
30. Templeton, N. S., Lasic, D. D., Frederik, P. M., Strey, H. H., Roberts, D. D. and Pavlakis, G. N. (1997) Improved DNA: liposome complexes for increased systemic delivery and gene expression. Nat. Biotechnol. 15, 647-652.